Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Hydromorphone hydrochloride 50mg/ml Solution for Injection/Infusion – PA0549/030/002
- Kemadrin 5mg Tablet – PA1691/005/001
- Seretral 50mg Film Coated Tablet – PA0749/023/001
- Seretral 100mg Film Coated Tablet – PA0749/023/002
- Serimel 100mg Film Coated Tablet – PA0126/135/002
- Tradol SR 100mg Prolonged Release Tablet – PA0711/029/005
- Yasminelle 0.02mg/3mg Film Coated Tablet – PA1410/015/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Candist Plus 16mg/12.5mg Tablet – PA0126/207/002
- Celecoxib 100mg Capsule – PA0711/241/001
- Cimeldine 400mg Tablet – PA0126/077/002
- Emazole 40mg Tablet – PA0711/158/002
- Ezetimibe Simvastatin 10mg/10mg Tablet – PA0126/281/001
- Folinic acid 10mg/ml Solution for Injection (100mg/10ml presentation) – PA0822/198/003
- Galfer 305mg Tablet – PA0126/314/001
- Losamel 20mg Gastro-resistant Tablet – PA0126/115/001
- Melfen 200mg Film Coated Tablet – PA0126/012/001
- Miramel 0.18mg Tablet – PA0126/173/002
- Neurontin 800mg Capsule – PA0822/015/005
- Nexium Control 20mg Tablet – EU/1/13/860/001-002
- Serlan 50mg Film Coated Tablet – PA0711/065/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.